Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia von de Oliveira Costa, J, Lin, J, Milder, TY, Greenfield, JR, Day, RO, Stocker, SL, Neuen, BL, Havard, A, Pearson, SA, Falster, MO

Volltext bestellen